VIKING GLOBAL INVESTORS LP
CIK 1103804 · last filed 2024-02-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.11B
Companies
7
Total Filings
13
Lifetime Open-Market Net
-$529.26M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RayzeBio, Inc. (RYZB) Delisted | 10%+ Owner | 1,285,223 | $62.49 | $80.31M | $200.00M | 1 | 2023-09-21 |
| Frazier Lifesciences Acquisition Corp (FLACW) Delisted | 10%+ Owner | 1,211,582 | $0.80 | $969.3K | $68.31M | 1 | 2022-11-04 |
| FIGS | 10%+ Owner | 14,785,102 | $10.33 | $152.73M | -$65.49M | 1 | 2021-09-03 |
| RLYB | 10%+ Owner | 524,347 | $16.16 | $8.47M | $73.35M | 1 | 2021-08-02 |
| ADPT | 10%+ Owner | 29,993,708 | $22.52 | $675.46M | -$1.37B | 2 | 2020-12-16 |
| BBIO | 10%+ Owner | 26,620,991 | $85.55 | $2.28B | $560.00M | 1 | 2019-06-28 |
| Urovant Sciences Ltd. (UROV) Delisted | 10%+ Owner | 22,791,378 | $16.24 | $370.13M | $1.93M | 2 | 2019-06-06 |
Recent Filings · Page 2 of 2
13 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-06 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +147,854 | $1.16M | EDGAR |
| 2019-05-29 | Urovant Sciences Ltd. (UROV) Delisted | Buy (P) | +101,395 | $773.2K | EDGAR |
| 2019-03-19 | — | Buy (P) | +46,666,669 | $70.00M |
Showing 11–13 of 13
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.